Table 1 Patient’s biochemical profile at admission to our unit, after therapy adjustments and at the last follow-up visit
From: Shrinkage of a pituitary metastasis of melanoma induced by pembrolizumab: a case report
Parameters and units | Admission values (26 June 2018) | First follow-up visit (26 July 2018) | Last follow-up visit (24 June 2020) | Normal values |
|---|---|---|---|---|
Prolactin (µIU/ml) | 482 | – | 410.63 | 86–324 |
FSH (mIU/ml) | 1.2 | – | – | 1.5–12.4 |
LH (mIU/ml) | 0.3 | – | – | 1.7–8.6 |
Total testosterone (ng/dl) | 2.50 | – | – | 193–386 |
IGF-1 (ng/ml) | 36.34 | – | – | 47–141 |
Cortisol (µg/dl) | 18.52 | 21.40 | 13.5 | 7–32 |
UFC (µg/24 hours) | 428.06 | 274.60 | – | 30–350 |
FT4 (pmol/L) | 10.30 | 15.60 | 12.61 | 12.0–22.0 |
TSH (µIU/ml) | 0.033 | 0.023 | 0.02 | 0.27–4.2 |